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Abstract
By physically destroying typhoid bacilli and centrifuging at a high speed, an insoluble granu-
lar fraction (P1) and soluble fraction (S1) were obtained. Chemical and enzymologic properties of
these substances as well as their influences on the protective ability against infection were studied;
and the following results were attained: 1. P1 contains an extremely small amount of proteins
when compared with S1. 2. The enzymologic activity of P1 is entirely different from that of S1.
In P1 the respiratory enzyme system of only lactate and succinate is localized. 3. Although both
P1 and S1 possess the antibody-producing ability in serum of rabbit to the same high degree, P1
imparts to mice a markedly high protective ability against infection. 4. By the heat-treatment of
P1 its antigenicity is lost at the same time.
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The methods for imparting the protective immunity in vivo can
roughly be divided into two categories; namely the one by dead virulent
bacteria 1-3, and the other by living non-virulent bacteria 4. However,
if the former method is supposed to owe its immunizing power to some
components of bacteria bearing the virulence, then it would be difficult
to explain the effectiveness of the immunity in the latter. Furthermore,
the gram-negative bacilli, especially in the Samonella and Shigella
groups, it is said that S form possesses a superior immunogenicity than
R form; and this fact indicates that the presence or absence of O-anti-
gen has an important bearing on the protective immunity. That the
protective antigen is chemically not a single substance is obvious from
the fact the a-antigen (toxin within the body of bacillus) is identified as
lipid-polysaccharides-peptides 5-7.
On the other hand, there is no concrete evidence to prove that the
antigen-antibody reaction such as the agglutination reaction and the pre-
cipitation reaction as observable in vitro would play any role in the me-
chanism of the immunologic resistance8 • DUBOS9 likewise states that
~n whatever manner the toxin in the body of bacilli may be inoculated,
the immune state of the animals is never high and does not last any length
of time either. Despite this he contends that the precipitin values against
the toxin can easily be attained in a high degree.
The recent advance in the enzyme chemistry is gradually elucidating
the fine structures and the physiological significance of the bacterium. This
has especially an important bearing on the heredity and bio-synthesis,
but the report in which it is introduced into the immunologic phenomena
15
1
Murakami et al.: Studies on prevention of infection (II) The enzymologic traits
Produced by The Berkeley Electronic Press, 1959
16 S. MURAKAMI, K. YOSHIOKA, Y. aKA, Y. MATSUURA
is amost negligible.
As long as proteins play a leading role in the revelation of immuni-
ty, the authors are of the opinion that it must have an intimate relation-
ship with the mechanism of biosynthesis. Therefore, in the present study
of the protective immunity, the authors have investigated the role that
will be played by enzyme active substances within the body of bacteria.
MATERIALS AND METHODS
Test strains. The test bacilli are all typhoid bacilli consisting of
S 57, S 58, S 57-R, A-2, and A-63, the last two possessing Vi-antigen.
S 57-R is the R form derived from S 57 in our laboratory.
After culturing on agar medium 20 to 24 hours, they are collected in
the mortar and are ground hard (at aOe) with quartz sand one hour. To
this thick paste 0.02 mol phosphate buffer solution (pH 7.0) is added in
the proportion of 2 ml to 1 g of the wet bacilli, and after stirring thoro-
ughly, the mixture is centrifuged 30 minutes at 10000 rpm. This supe-
rnatant is again centrifuged at the high speed of 15000 rpm 30 minutes
and then a transparent supernatant is obtained. This transparent supe·
rnatant is still further centrifuged at the high speed of 40000 rpm one
hour, and the supernatant (hereafter abbreviated as SJ) and the precipi-
tate (PJ) are separated. For the study of the enzyme activity and the
antigenicity PI is diluted in ratio of 1 ml phosphate buffer solution to PJ
from 19 the wet bacilli; and SJ as it stands is used as the standard.
The enzyme activity has been estimated by Warburg's apparatus.
For the test animals normal mice weighing 15 to 18g are selected.
EXPERIMENTAL RESULTS
A. The general chemical properties and enzymatic activity of SI
and P1
SI is a light yellowish transparent substance and seems to be a solu-
ble portion, While P l is a reddish brown substance and it belongs to an
insoluble granular fraction. Their chemical properties are shown in
Table l.
In Table 1 the characteristic traits of SI and PI of A-2 are shown,
and Sl demonstrated both the Biuret and Molish reactions quite strongly
and the amount of N is as high as ten times that of P l •
Next, Table 2 shows -the enzymatic activity of SI and PJ in each
2
Acta Medica Okayama, Vol. 13 [1959], Iss. 1, Art. 2
http://escholarship.lib.okayama-u.ac.jp/amo/vol13/iss1/2
Studies on Prevention of Infection (11)
Table 1. Chemical Traits of Fractions
reaction
fraction
I IBiuret Molish Kyeldahl
SI
I
+H-
I
+H-
I
N 600mg/dl
PI ± + N 60mg/dl
17
SI is prepared by adding 0.02 mol phosphate buffer solution (pH 7.0) in propor-
tion of 2 ml to 1 g of the original wet bacilli
PI is prepared by adding 0.02 mol phosphate buffer solution in the proportion
of 1 ml to 1 g of the original wet bacilli
Table 2. Enzymological Characteristics (02-consumption) of SI
and PI of Various Typhoid Bacilli
~ 5 57-R
I
557 5 58
I
A-63 A-2
~ I I I I Isubstrate SI PI SI PI SI PI SI PI SI PI
endogenous 128 0 120 4 1 122 I 1 124 4 116 3
pyruvate 112 0 110 6 130 7 117 6 120 9
lactate 206 63 104 147 232 162 144 107 154 84
acetate 123 5 129 14 126 8 120 7 124 4
citrate 211 6 123 5 121 0 173 3 131 6
succinate 192 44 140 72 152 62 162 69 157 51
malate 144 6 136 3 99 2 137 4 127 5
glucose 167 3 132 5 136 3 134 1 141 3
catalase I +H- I ± I +H- I ± I +H-I ± I+H- I ± I+H- I ±I
Content: 51 (p\)· ..2 ml, substrate· ..0.3 ml of 0.1 mol substrate. To the above 0.7
ml of 0.02 mol phosphate buffer solution (pH 7.0) is added, so that the final volume
will be 3 ml.
The estimated values are for the duration of two hours.
strain with addition of various substrates.
As shown in Table 2, S1 of each strain shows a high endogenous
respiration, making it difficult to judge the efficacy of the addition
of substrate, and it is especially true of all SI with an exception of
S 57--R, show a fairy marked oxidation of lactate, citrate, and succi-
nate.
Now, looking at the activity of Ph in all strains of typhoid bacilli
lactate and succinate are specifically oxidized, and other substrates are
not at all oxidized. And it is also interesting to note that catalase of every
5J is strongly positive, while that of PJ is almost negative. This result
3
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is exactly identical with the result obtained by Millman10 in his observa-
tions of tubercle bacilli.
B. The antigenicity of 51 and P1
In the first experiment, instead of attacking with the typhoid bacilli
loaded with mucine, the protective ability against septicemia has been
determined by inoculating a large dose of bacilli. Table 3 shows the result
obtained in the groups of mice treated by the heat-killed 5 57, 51 or P1
and later attacked by 1.5 mg of 5 57.
Table 3. Comparison of the Protective Ability against Infection
immunization treatment I mouse groups
contol I • • • • • • • • • 0
557 (heated one hour
I
• • • • • • • • • •
at 56 C) 5 mg • • • • • 0 0 0 0 0
557.... ··51
I
• • • • • • • • • •0.25 ml • 0 0 0 0 0 0 0 0 0
557.. ·.. ·PI
I
• 0 0 0 0 0 0 0 0 00.25 ml 0
Attacked ip with 1. 5 mg 557 strain two weeks after the inoculation
Namely, the order of their protective ability is the heat-killed bacilli
<51 <Ph and the protective ability of P1 is especially of a high degree.
In addition, 51 likewise shows an ability as shown in Table 3, but this
treatment brings about comparatively strong side effect. This seems to
be due to a high concentration of proteins as already mentioned.
From these results it has become clear that P1 of 5 57 possesses
a marked protective antigenicity. Therefore, with the purpose to study
to what extent of dilution this might be efficacious, the protective ability
of the mice has been observed by treating the animals with diluted P1
of 557, S 57-R in various multiples. One and half milligrams of 5 57 is
used for the attack. The results are shown in Table 4.
P1 of 5 57 demonstrates the protective power completely up to the 8-
fold dilution, but P1 of S 57-R does not at all show any effect against the
attack of 5 57. Of course, Sj of S 57-R is ineffective and the heat-killed
5 57-R shows a slight effect. '
Next, ten mice are treated with p] of S 58, and the five of them are
attacked with 5 57 as in the former case, while the other five are attacked
4
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Table 4. Influences of PI and SI of the S., R- form Strains
on Protection agaist Infection
19
material for vaccination
I
dilution multiples
and doses 1 2 4 8 16
S 57, PI 0.25101 5/5 5/5 5/5 5/5 3/5
S 57, heat-killed bacilli 5mg (0/5)
untreated control (1/5)
S 57-R, PI 0.25101 0/6 1/5 0/5 0/5
S 57-R, SI 0.25101 0/5 1/5
S 57-R, heat-killed bacilli 5mg (2/5)
untreated control (0/7)
Attacked i p with 1.5 109 S57 strain 2 weeks affter treatment.
Denominator indicates number of mice attacked.
Numberator indicates number of mice survived.
with S 58. The results, as shown in Table 5, reveal that the animals can
not resist against the attack of S 57, but they can protect themselves
against the attack of the similar strain, S 58.
Table 5. Comparison of the Protective Ability against S 57 and
S 58 in Mice treated with PI of S 58-Strain
materials fo. vaccination I dilution 1 group attacked with
I
group attacked with
multiples 1.5 109 S 57-strain 1.5 109 S 58-strain
S 58 2 • • • • • • 0 0 0 0
PI 4 • • • • 0
dose of 0.25101 each 8 • • • • 0
untreated control I • • • • • • • • • •
As the vaccine now commonly used contains Vi-antigen, P10f A-2
strain that contains this antigen has been prepared. Then PI is diluted in
various steps up to 14, 336-fold dilution, and after treating mice with the
diluted Ph on the second week the animals are. attacked with A-63 strain
possessing Vi-tantigen and loading it with 5 % mucine. The results are
shown in Table 6.
It has been found that up to the 28·fold dilution P1shows a protective
power against 104 MLD though slightly; against 103 MLD up to the 112·
fold dilution completely; against 102 MLD as high as to the 1,792-fold
dilution; and against 10 MLD it shows almost completely the protective
ability up to the 3,584·fold dilution. In addition, against 1 MLD P1shows
5
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Table 6. Estimation of the Protective Ability of PI-A-2
I dilution multiples of PI of A-2
I
14 21 28 32 42
A·63 attack dose (MLD) 104 2/5 1/5 2/5 1/6 0/6
dilution multiples of PI. A-2 I 56 84 112 168 224 336 448
A-63. Attack dose (MLD) 103 6/6 4/6 6/6 4/6 4/5 2/5 1/5
dilution multiples of PI. A-2 336 448 672 896 1344 1792
A-63. attack dose (MLD) 102 5/6 6/6 6/6 4/5 3/5 3/5
dilution multiples of PI. A-2 896 1344 1792 2688 3584
A-63. attack dose (MLD) 10 I 6/6 6/6 6/6 3/6 6/6
dilution multiples of PI. A-2 1528817168 10576 14336
A-63. attack dose (MLD). 1 I 6/6 6/6 5/5 3/4
control attacked with 1 MLD
I
0/9)
Mice treated with variously diluted PI of A-2 were attacked with 1......104 MLD of
A-63 strain two weeks after the treatment.
Denominator signifies number of mice attacked.
Numerator indicates number of mice survived.
almost complete protection up to the l4,366-fold dilution.
The result of the study on the protective ability by the attack method
of 10 LDoo is shown in Table 7.
Table 7. Evaluation of the Protective Aility by Attack Methods of LD50
method of treatm=nt I survivals I attacking strain
No. 1 A-2, PI at the dil. of 103
\
14/20 A-63dose···0.5 ml
No.2 A-2, PI at dil. of 104 12/20 A-63dose"·0.5 ml
untreated control 0/5 A-63
Denominator.. 'number of test mice
Numerator"'number of mice survived
As shown in the above table, each P1 of A·2, diluted 103-fold and
104·fold, is inoculated to the groups of 20 mice each, and their protective
ability against A-63 has been studied. Fourteen mice of the group treated
with the dose of 0.5 ml of the 103·fold dilution survived, while 12 mice of
the group treated with the 104·fold dilution were able to survive. In other
words, in both groups over 50 per cent of the animals survived, showing
a marked protecitive ability. This proves that the effective concentration
of vaccine may be as dilute as lOO-fold.
6
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P1 of A-2, as is clear from the above results, shows a marked protec-
tive antigenicity, the degree of efficacy of 5J has been compared with the
vaccine now sold in the market. The vaccine (A-58 Vi) bought in the
common market is one year old; and the result is shown in Table 8.
Table 8. Protective Ability of 51 and Vaccine sold in the Market
method of vaccination I dose of attack I survivals
0.5 ml of vaccine in market 104 0/6
(A58 vi) diluted 7-fold 103 3/6
No. 1 102 5/6
0.5 ml of 51 of A-2 104 0/6
diluted 35-fold 103 1/6
No. 2 102 4/6
untreated control I 1 I 1/6
Denominator···number of test mice
Numerator···number of mice survived
As can be seen in Table 8, the vaccine obtained in the market shows
a high protective ability against 102 MLD, but against 103MLD the abili-
ty is of an intermediate degree.
• The mice treated with 51 of A-2 diluted 35·fold show a lower protec-
tive ability than in the case of the mice treated with the market vaccine
(since 51 which contains a large amount of protein shows a strong side
effect at the dilution around 7-fold, it is used at the 35-fold dilution).
Therefore, the protective ability of 5h when compared with that of Ph is
indeed trival.
Our next step is to see what influences heating will have on P 1 of A-2,
which showed such a remarkable effect. Namely, PJ of A-2 is divided
into the 50·fold dilution and the 150-fold dilution, and each diluted solu-
tion is heated 30 minutes at 100 C or 56 C. The protective ability against
infection in the mice treated with PJ heated variously as above is shown
in Table 9.
Namely, regardless of whether heated at 100 or 56 C, P1 whose enzy-
matic activity thus being inactivated loses completely its protective abili-
ty.
P1 of A-2 demonstrates, as mentioned above, a high degree of resis-
tance against the bacilli possessing Vi-antigen, but the result of the study
in which its reaction against S. paratyphi B which has different agntigen
7
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Table 9. Effect of Heating on Protective Ability
method of vaccination I attack dose I survivals(MLD)
PI diluted 50-fold 102 0/5
(0.5 m}) 10 1/5heat 30 min
at 100 C 102 0/5PI diluted 150-fold
(0.5 ml) 10 0/5
PI diluted 50-fold 103 1/5
(0.5 ml) 102 1/5hea ted 30 min
at 56 C 103 0/5PI diluted 150-fold
(0.5 ml) 102 0/5
untreated control I 1 I 0/5
PI used for vaccination is derived from A-2 strain.
the attack strain· ..A-63
Denominator .. ·number of test mice
Numerator .. ·number of mice survived
Table 10. Protective Ability of A-2 against S. paratyphi B
method of vaccination I attack dose I survivals
0.5 ml of PI. A-2 diluted 84-fold 10 0/5
0.5 ml of PI. A-2 diluted 112-fold 1 1/5
untreated control 1 0/5
structures is shown in Table 10.
As shown in Table 10, P1 in the dilution of 84-fold and of 112·fold
shows no protective ability at all, revealing a striking specificity.
The next step is to see the grades of the local responses in the case
where the intra-cutaneous inoculation of respective 51 and P1 of living
and dead A-2 bacilli is administered to normal rabbits. The result of this
observation is illustrated in Table 1l.
As can be understood from Table 11, the grades of responses to such
inoculations are in the order to P1>51 = dead bacilli <living bacilli. In
other words, in the case with living bacilli a marked response can be re-
cognized even 5 days after the treatment, but in the case with dead ba-
cilli and 51 even after 5 days solidification can still be seen though slight.
In contrast to these in the case with P1 three days after treatment no
local reaction can at all be observed. This is true in the case of the sub-
8
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Table 11. Comparison of Intra-Cutaneous Responses in Rabbits treated
with Various SUbstrates
23
days after inoculation I 3 days I 5 days
inoculum I-------I~-:~ responses I sed.
\
consoli- I sed. I
consoli.
dose _________ test dation test dation
0.1 mg I lOmml -Ht 15mm -Ht
living bacilli
I I0.01 mg 5 *
10 -Ht
0.1 mg 5 + - ±
dead bacilli
0.1 mg 2 ? - ±
0.1 ml ot 10-fold dilution 4 + - ±
SI
0.1 ml of lOO-fold dilution 2 ? - ±
0.1 ml of 10-fold dilution - - - -
I PI
I 0.1 ml of 100·fold dilution - - - -
Vaccines are all derived from A-2 strain.
cutaneous inoculation as well.
The final step is to find out what responses would mice present when
they are treated with PJ of A-2, and this is performed as a safety mea-
sure. Likewise a similar experiment has been conducted with 5 j •
Table 12. Safety Tests of PI and SI
- i~:l1Um I
dilution -~____________
4-fold
5-fold
6-fold
7-fold
Dose is 0.5 ml in each case.
•
•
o
A-2.
•
•
o
•
o
o
•
o
o •
o
A-2.
•
o
o
o
o
o
When PJ in the dilution up to 5-fold is given, it presents strong side
effects, even proving to be fatal to some, but it is perfectly safe in the
dilution of over 5-fold. However, 5 J is not safe even at the dilution of 6-
fold, and it is only safe at the dilution over 7-fold.
Briefly, P l can impart a sufficient protective power to mice even as
high a dilution as over 7-fold, while 5 j even at the concentration where
side effect appears can give only a slight protective ability.
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SUMMARY AND DISCUSSION
Immunity, the term commonly used today, gives an impression of
including the entire range of the antigen-antibody reactions. Such phe-
nomena as the resistance of host against pathogenic bacteria and antibo-
dies being produced in the body of animal as specific responses against
the injection of all kinds of antigenic substances are all interpreted as the
results of the immunization treatment. Moreover, the aspect of antibody
production against a pathogenic antigen is interpreted as the resistance
against infection, and the same is true with respect to an antibody bene-
fitial to the host or to a harmful antibody eliciting allergic conditions.
Would this not be due to the fact that the interpretation ef the fluid im-
munity is based on antibody as its core? On the other hand, cell immuni-
ty seems to depend upon phagocytosis but this does not always mean im-
munityl1,12.
Recently KOBAYASHI et al. state that in all likelihood the tissue
mechanism is responsible for the protection against infection in experi-
mental typhus of animals. This seems to mean the protection is not solely
dependent upon fluid antibody. ANDO and his co-workers2 likewise ex-
plain more concretely the opinion of KOBAYASHI et al. 13 in their mouse
experiments with S. enteritidis and S. cholerae suis. Namely, they pro-
pose that the fractions such as mitochondria and microsomes are the cell
factors controlling the susceptibility and resistance of a host.
The authors have pursued to see what active fractions of bacterial
cells are most deeply involved in the protection against infection, but not
from the standpoint of tissues of a host.
The reason that PJ has much less side effect than 51 seems to be due
to its markedly low protein contents as already shown in Table 1. Fur-
thermore, as shown in Table 2 from the fact that PJ specifically oxidizes
only lactate and succinate and possesses the electron transport system
intact, PI has traits quite similar to mitochondria of animal cells. Those
mice treated with this PI escaped death from septicemia due to the attack
of a large dose of bacilli (Tables 3,4, 5), but 51 yielded far poorer results
(Tables 3,). Whereas in the previous experiments both 51 and P J demon-
strated antibody in a high degree. In other words, this is an interesting
fact in that antibody can be differentiated from the protective ability as
two separate entities. In addition, the specificity of the protective ability
is extremely marked; for instance, those mice treated by PI of 5 58 or
5 57-R could not endure the attack of 5 57 given in a large dose (Tables
4, 5).
In order to clarify these preliminary experiments still further the
10
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protective antigenicity has been studied with lethal dose. Mucine was
added to all the bacilli used in attack. Namely, by diluting PI of the A-2
strain possessing Vi-antigen into various dilutions its protective powerimparted to test animals was studied while being attacked by the A-63
strain (bacilli possessing Vi-antigen), and the results obtained are as ex-
cellent as shown in Tables 6 and 7. For example, the mice treated with
PJ diluted 224-fold could resist the attack of 103MLD in a high proportion;
and even when treated with PJ diluted as high as 672-fold they coud com-pletely endure the attack of 102 MLD.
On the other hand, the protective power of the mice treated with Sj
of the A-2 strain was extremely low, even being inferior to the one year
old vaccine sold in the market. It has also been demonstrated that Vi-
antibody is formed in serum when rabbit is treated with this SI. There-fore, to what extent the evidence proving the presence of Vi-antibody is
associated with the protection ~gainst infection is open to question.
PJ' that seems to show enzymologically a characteristic activity and
to have an intimate relation to the antigenicity, is inactivated by heating
and this inactivated PI is inoculated to mice to see whether or not the
mice would show any protective ability. As the result the ability hasbeen found almost completely inactivated as shown in Table 6. This
seems to suggest that the antigenicity has some relationship with the en-
zymologic activity of the antigen introduced. This point will be lookedinto in our future study. It is clear from Table 10 that the treatment with
PI of A-2 imparts a strong protection against the A-63 attack, but the
same treatment can not at all impart any protective power against the
attack of S. paratyphi B. possessing different antigen structures. Again,
the reaction at the site of inoculation is the mildest as shown in Table 11.
CONCLUSIONS
By physically destroying typhoid bacilli and centrifuging at a high
speed, an insoluble granular fraction (p)) and soluble fraction (SI) were
obtained. Chemical and enzymologic properties of these substances as
well as their influences on the protective ability against infection were
studied; and the following results were attained:
1. PJ contains an extremely small amount of proteins when comparedwith Sj.
2. The enzymologic activity of P j is entirely different from that ofSI. In PI the respiratory enzyme system of only lactate and succinate islocalized.
11
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3. Although both P1 and 51 possess the antibody-producing ability in
serum of rabbit to the same high degree, P1 imparts to mice a markedly
high protective ability against infection.
4. By the heat-treatment of Ph its antigenicity is lost at the same
time.
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